Your browser doesn't support javascript.
loading
SUMO promotes DNA repair protein collaboration to support alternative telomere lengthening in the absence of PML.
Zhao, Rongwei; Xu, Meng; Yu, Xiaoyang; Wondisford, Anne R; Lackner, Rachel M; Salsman, Jayme; Dellaire, Graham; Chenoweth, David M; O'Sullivan, Roderick J; Zhao, Xiaolan; Zhang, Huaiying.
Affiliation
  • Zhao R; Department of Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA.
  • Xu M; Department of Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA.
  • Yu X; Department of Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA.
  • Wondisford AR; Department of Pharmacology and Chemical Biology, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
  • Lackner RM; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19014, USA.
  • Salsman J; Department of Pathology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
  • Dellaire G; Department of Pathology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
  • Chenoweth DM; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19014, USA.
  • O'Sullivan RJ; Department of Pharmacology and Chemical Biology, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
  • Zhao X; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
  • Zhang H; Department of Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA; huaiyinz@andrew.cmu.edu.
Genes Dev ; 2024 Jul 22.
Article in En | MEDLINE | ID: mdl-39038850
ABSTRACT
The alternative lengthening of telomeres (ALT) pathway maintains telomere length in a significant fraction of cancers that are associated with poor clinical outcomes. A better understanding of ALT mechanisms is therefore necessary for developing new treatment strategies for ALT cancers. SUMO modification of telomere proteins contributes to the formation of ALT telomere-associated PML bodies (APBs), in which telomeres are clustered and DNA repair proteins are enriched to promote homology-directed telomere DNA synthesis in ALT. However, it is still unknown whether-and if so, how-SUMO supports ALT beyond APB formation. Here, we show that SUMO condensates that contain DNA repair proteins enable telomere maintenance in the absence of APBs. In PML knockout ALT cell lines that lack APBs, we found that SUMOylation is required for manifesting ALT features independent of PML and APBs. Chemically induced telomere targeting of SUMO produces condensate formation and ALT features in PML-null cells. This effect requires both SUMOylation and interactions between SUMO and SUMO interaction motifs (SIMs). Mechanistically, SUMO-induced effects are associated with the accumulation of DNA repair proteins, including Rad52, Rad51AP1, RPA, and BLM, at telomeres. Furthermore, Rad52 can undergo phase separation, enrich SUMO at telomeres, and promote telomere DNA synthesis in collaboration with the BLM helicase in a SUMO-dependent manner. Collectively, our findings suggest that SUMO condensate formation promotes collaboration among DNA repair factors to support ALT telomere maintenance without PML. Given the promising effects of SUMOylation inhibitors in cancer treatment, our findings suggest their potential use in perturbing telomere maintenance in ALT cancer cells.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Genes Dev Journal subject: BIOLOGIA MOLECULAR Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Genes Dev Journal subject: BIOLOGIA MOLECULAR Year: 2024 Type: Article Affiliation country: United States